Berna Biotech AG insider transactions
Management transactions
0
Shareholding disclosures
9
First disclosure
03.09.2001
Last disclosure
02.02.2006
Company summary
No management purchase or sale disclosed in the last 90 days.
- Latest purchase
- —
- Net flow 90 d
- CHF 0.00
- Top shareholder
- 73.91%
—
Buys − sales
Crucell N.V
This page brings together all Berna Biotech AG (BERNA) insider transactions: 0 management transactions and 9 significant shareholding disclosures published by SIX Exchange Regulation, from 03.09.2001 to 02.02.2006.
Detailed context
Berna Biotech AG has recorded a total of 0 insider transactions and 9 significant shareholding disclosures published by SIX Exchange Regulation. Within the last 90 days, the company registered 0 purchases valued at CHF 0 and 0 sales valued at CHF 0, with no latest management transaction date reported. The largest declared shareholders by voting rights include Crucell N.V at 73.91%, Eaton Vance Emerald Worldwide Health Science Fund at 13.69%, OrbiMed Advisors LCC at 13.69%, and OrbiMed Advisors Inc at 9.99%.
Insider barometer
90 days
No transaction in this window
Latest transaction
—
Largest purchase
—
Largest sale
—
These figures aggregate public disclosures. They are not investment advice.
insider24.ch
Follow Berna Biotech AG’s disclosures
Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.
Need more? Discover the Pro plan
Berna Biotech AG insider transactions
No management transaction disclosed for this company.
Latest shareholding disclosures
Berna Biotech AG
7 people · Eaton Vance Worldwide Health Sciences Portfolio…
Berna Biotech AG
Global Opportunities Fund · Group of shareholders
Berna Biotech AG
ING Bank N.V · Group of shareholders
Berna Biotech AG
Crucell N.V · Group of shareholders
Berna Biotech AG
Global Opportunities Fund · Group of shareholders